Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 804

1.

Incidence and risk factors for immune reconstitution inflammatory syndrome during highly active antiretroviral therapy.

Shelburne SA, Visnegarwala F, Darcourt J, Graviss EA, Giordano TP, White AC Jr, Hamill RJ.

AIDS. 2005 Mar 4;19(4):399-406.

PMID:
15750393
2.

Incidence and risk factors of immune reconstitution inflammatory syndrome complicating HIV-associated cryptococcosis in France.

Lortholary O, Fontanet A, Mémain N, Martin A, Sitbon K, Dromer F; French Cryptococcosis Study Group.

AIDS. 2005 Jul 1;19(10):1043-9.

PMID:
15958835
3.

Role of hepatitis C virus (HCV) viremia and HCV genotype in the immune recovery from highly active antiretroviral therapy in a cohort of antiretroviral-naive HIV-infected individuals.

Antonucci G, Girardi E, Cozzi-Lepri A, Capobianchi MR, De Luca A, Puoti M, Petrelli E, Carnevale G, Rizzardini G, Grossi PA, Viganò P, Moioli MC, Carletti F, Solmone M, Ippolito G, Monforte AD; HepaI.Co.N.A. Study Group; Italian Cohort Naive for Antiretrovirals Study Group.

Clin Infect Dis. 2005 Jun 15;40(12):e101-9. Epub 2005 May 5.

PMID:
15909251
4.

Immune reconstitution inflammatory syndrome in adult human immunodeficiency virus-infected patients in Thailand.

Aramaki M, Silachamroon U, Desakorn V, Maek-A-nantawat W, Waiwaruwut J, Jutiwarakun K, Kim JH, Pitisuttithum P.

Southeast Asian J Trop Med Public Health. 2010 Jan;41(1):138-45.

PMID:
20578492
5.

Successful discontinuation of therapy for disseminated Mycobacterium avium complex infection after effective antiretroviral therapy.

Shafran SD, Mashinter LD, Phillips P, Lalonde RG, Gill MJ, Walmsley SL, Toma E, Conway B, Fong IW, Rachlis AR, Williams KE, Garber GE, Schlech WF, Smaill F, Pradier C.

Ann Intern Med. 2002 Nov 5;137(9):734-7.

PMID:
12416943
7.

Comparison of clinical response to initial highly active antiretroviral therapy in the patients in clinical care in the United States and Brazil.

Grinsztejn B, Veloso VG, Pilotto JH, Campos DP, Keruly JC, Moore RD.

J Acquir Immune Defic Syndr. 2007 Aug 15;45(5):515-20.

PMID:
17558332
8.

The clinical epidemiology of Hodgkin lymphoma in HIV-infected patients in the highly active antiretroviral therapy (HAART) era.

Vilchez RA, Finch CJ, Jorgensen JL, Butel JS.

Medicine (Baltimore). 2003 Mar;82(2):77-81.

9.

Nontuberculous mycobacterial immune reconstitution syndrome in HIV-infected patients: spectrum of disease and long-term follow-up.

Phillips P, Bonner S, Gataric N, Bai T, Wilcox P, Hogg R, O'Shaughnessy M, Montaner J.

Clin Infect Dis. 2005 Nov 15;41(10):1483-97. Epub 2005 Oct 12.

PMID:
16231262
10.

Improved outcomes of HIV-1-infected adults with tuberculosis in the era of highly active antiretroviral therapy.

Hung CC, Chen MY, Hsiao CF, Hsieh SM, Sheng WH, Chang SC.

AIDS. 2003 Dec 5;17(18):2615-22.

PMID:
14685055
11.

Tuberculosis manifested by immune reconstitution inflammatory syndrome during HAART.

Park WB, Choe PG, Jo JH, Kim SH, Bang JH, Kim HB, Kim NJ, Oh MD, Choe KW.

AIDS. 2007 Apr 23;21(7):875-7.

PMID:
17415046
12.
13.

The prevalence and risk of immune restoration disease in HIV-infected patients treated with highly active antiretroviral therapy.

Jevtović DJ, Salemović D, Ranin J, Pesić I, Zerjav S, Djurković-Djaković O.

HIV Med. 2005 Mar;6(2):140-3.

14.

Improved virological response to highly active antiretroviral therapy in HIV-1-infected patients carrying the CCR5 Delta32 deletion.

Laurichesse JJ, Persoz A, Theodorou I, Rouzioux C, Delfraissy JF, Meyer L.

HIV Med. 2007 May;8(4):213-9.

15.

The incidence of and risk factors for HIV-associated cognitive-motor complex among patients on HAART.

Jevtović Dj, Vanovac V, Veselinović M, Salemović D, Ranin J, Stefanova E.

Biomed Pharmacother. 2009 Sep;63(8):561-5. doi: 10.1016/j.biopha.2008.09.015. Epub 2008 Nov 5.

PMID:
19026516
16.

Immune reconstitution inflammatory syndrome among HIV/AIDS patients during highly active antiretroviral therapy in Addis Ababa, Ethiopia.

Huruy K, Mulu A, Mengistu G, Shewa-Amare A, Akalu A, Kassu A, Andargie G, Elias D, Torben W.

Jpn J Infect Dis. 2008 May;61(3):205-9.

17.
18.

Immune restoration disease after the treatment of immunodeficient HIV-infected patients with highly active antiretroviral therapy.

French MA, Lenzo N, John M, Mallal SA, McKinnon EJ, James IR, Price P, Flexman JP, Tay-Kearney ML.

HIV Med. 2000 Mar;1(2):107-15.

19.

Immune reconstitution inflammatory syndrome in the first year after HAART: influence on long-term clinical outcome.

Park WB, Choe PG, Jo JH, Kim SH, Bang JH, Kim HB, Kim NJ, Oh MD, Choe KW.

AIDS. 2006 Nov 28;20(18):2390-2.

PMID:
17117028
20.

Does immune reconstitution syndrome promote active tuberculosis in patients receiving highly active antiretroviral therapy?

Breen RA, Smith CJ, Cropley I, Johnson MA, Lipman MC.

AIDS. 2005 Jul 22;19(11):1201-6.

PMID:
15990574

Supplemental Content

Support Center